Bharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....

The Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...

With Covid emerging as a renewed threat around the world, India is ramping up efforts to prevent another wave in the country, including res...

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a bo...

iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candid...

It may produce local antibodies in the upper respiratory tract - which could provide the potential to reduce infection and transmission.

According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...

The date of the meeting is yet to be fixed. India's drug controller had in January this year given permission to Bharat Biotech to conduct ...

The trials of the Intranasal vaccine will take place at nine different sites of the country.

BBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...

Most vaccines are administered by injection through intramuscular or subcutaneous route.